Shionogi, Florham Park, NJ

Shionogi

www.shionogi.com

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 140-year-old global pharmaceutical company with headquarters in Osaka, Japan. In the U.S., Shionogi Inc. leverages our science-based heritage to develop and commercialize pharmaceutical products to treat unmet medical needs in our core areas of infectious diseases and pain, as well as other areas of high medical need, including chronic liver disease.

Number of Employees: 250-1000
Annual Revenue: > $1 Billion

www.shionogi.com
300 Campus Drive Suite 300
Florham Park, NJ USA 07932
Phone: 973.966.6900

Executives

Name	Title	Contact Details
Joseph Spagnardi	Executive Vice President of Legal and Compliance	Profile
Ting Chen	Senior Vice President - US Regulatory Affairs	Profile
Andrew Zoltan	Vice President, Intellectual Property and Litigation	Profile
Gregory Montalbano	Corporate Counsel and Data Privacy Officer	Profile

Similar Companies

Akari Therapeutics

Akari Therapeutics is a clinical stage biopharmaceutical company focused on developing and commercializing treatments for rare and orphan autoimmune and inflammatory diseases caused by dysregulation of complement component 5 (C5). Its lead drug, Covers...

UCB SA

UCB SA is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Evoke Pharmaceuticals

Evoke Pharmaceuticals is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DeGolers Pharmacies

DeGolers Pharmacies is a Kansas City, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aeon Biopharma

Aeon Biopharma is leading the way as the first and only company focused solely on toxins for therapeutic applications. We are innovating toxin use to improve the lives of patients who are suffering from debilitating medical disorders. AEON is excited to introduce ABP450, the first 900 kDa toxin innovation in the US for over 30 years, and is proud to partner with physicians to advance treatment options. We are dedicated to enhancing patient lives by leading in new ways to use toxins while improving existing toxin therapy.